Gregory Evan Kraut

Gregory Evan Kraut discloses dealings in Sonnet BioTherapeutics Holdings, Inc. to SEC (Form 4). In total, 16 filings cover trades dated from 28 September 2016 to 15 December 2017.

On the market, this insider has only ever bought: 8 purchases, €24k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants. Since January 2017: 4 purchases and no sales on the market.

In size, the median ticket on the buying side is €2,923. On 7 out of 8 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 19 December 2017 with a share grant (€299) in Sonnet BioTherapeutics Holdings, Inc. The clock since the last published purchase (6 June 2017) now reads 3,443 days. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.